1 year return (CAGR)
87.22%
Compugen Exchange (NASDAQ, USD)
CGEN
2.49
+0.06 (+2.26%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
32.52%
5 year return (CAGR)
-16.57%
10 year return (CAGR)
-9.86%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
235.86M
Price/Sales
3.19
Ent value
275.21M
Price/Book
2.66
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-
Trailing P/E
6.70
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.46 |
| Daily high | 2.50 |
| Daily low | 2.40 |
| Daily Volume | 231K |
| All-time high | 19.45 |
| 1y analyst estimate | 4.60 |
| Beta | 2.78 |
| EPS (TTM) | 0.37 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 19 Feb 2026 |
Downside potential
Loading...
Downside potential data
| CGEN | S&P500 | |
| Current price drop from All-time high | -87.20% | -0.58% |
| Highest price drop | -97.90% | -56.47% |
| Date of highest drop | 24 Nov 2008 | 9 Mar 2009 |
| Avg drop from high | -75.91% | -10.68% |
| Avg time to new high | 505 days | 12 days |
| Max time to new high | 5019 days | 1805 days |
News
